1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Acromegaly Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Somatostatin Analogues 1.2.3 Dopamine Agonists 1.2.4 Growth Hormone Receptor Antagonists 1.2.5 Other 1.3 Market by Application 1.3.1 Global Acromegaly Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Acromegaly Market Perspective (2016-2027) 2.2 Acromegaly Growth Trends by Regions 2.2.1 Acromegaly Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Acromegaly Historic Market Share by Regions (2016-2021) 2.2.3 Acromegaly Forecasted Market Size by Regions (2022-2027) 2.3 Acromegaly Industry Dynamic 2.3.1 Acromegaly Market Trends 2.3.2 Acromegaly Market Drivers 2.3.3 Acromegaly Market Challenges 2.3.4 Acromegaly Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Acromegaly Players by Revenue 3.1.1 Global Top Acromegaly Players by Revenue (2016-2021) 3.1.2 Global Acromegaly Revenue Market Share by Players (2016-2021) 3.2 Global Acromegaly Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Acromegaly Revenue 3.4 Global Acromegaly Market Concentration Ratio 3.4.1 Global Acromegaly Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Acromegaly Revenue in 2020 3.5 Acromegaly Key Players Head office and Area Served 3.6 Key Players Acromegaly Product Solution and Service 3.7 Date of Enter into Acromegaly Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Acromegaly Breakdown Data by Type 4.1 Global Acromegaly Historic Market Size by Type (2016-2021) 4.2 Global Acromegaly Forecasted Market Size by Type (2022-2027) 5 Acromegaly Breakdown Data by Application 5.1 Global Acromegaly Historic Market Size by Application (2016-2021) 5.2 Global Acromegaly Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Acromegaly Market Size (2016-2027) 6.2 North America Acromegaly Market Size by Type 6.2.1 North America Acromegaly Market Size by Type (2016-2021) 6.2.2 North America Acromegaly Market Size by Type (2022-2027) 6.2.3 North America Acromegaly Market Size by Type (2016-2027) 6.3 North America Acromegaly Market Size by Application 6.3.1 North America Acromegaly Market Size by Application (2016-2021) 6.3.2 North America Acromegaly Market Size by Application (2022-2027) 6.3.3 North America Acromegaly Market Size by Application (2016-2027) 6.4 North America Acromegaly Market Size by Country 6.4.1 North America Acromegaly Market Size by Country (2016-2021) 6.4.2 North America Acromegaly Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Acromegaly Market Size (2016-2027) 7.2 Europe Acromegaly Market Size by Type 7.2.1 Europe Acromegaly Market Size by Type (2016-2021) 7.2.2 Europe Acromegaly Market Size by Type (2022-2027) 7.2.3 Europe Acromegaly Market Size by Type (2016-2027) 7.3 Europe Acromegaly Market Size by Application 7.3.1 Europe Acromegaly Market Size by Application (2016-2021) 7.3.2 Europe Acromegaly Market Size by Application (2022-2027) 7.3.3 Europe Acromegaly Market Size by Application (2016-2027) 7.4 Europe Acromegaly Market Size by Country 7.4.1 Europe Acromegaly Market Size by Country (2016-2021) 7.4.2 Europe Acromegaly Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Acromegaly Market Size (2016-2027) 8.2 Asia-Pacific Acromegaly Market Size by Type 8.2.1 Asia-Pacific Acromegaly Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Acromegaly Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Acromegaly Market Size by Type (2016-2027) 8.3 Asia-Pacific Acromegaly Market Size by Application 8.3.1 Asia-Pacific Acromegaly Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Acromegaly Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Acromegaly Market Size by Application (2016-2027) 8.4 Asia-Pacific Acromegaly Market Size by Region 8.4.1 Asia-Pacific Acromegaly Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Acromegaly Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Acromegaly Market Size (2016-2027) 9.2 Latin America Acromegaly Market Size by Type 9.2.1 Latin America Acromegaly Market Size by Type (2016-2021) 9.2.2 Latin America Acromegaly Market Size by Type (2022-2027) 9.2.3 Latin America Acromegaly Market Size by Type (2016-2027) 9.3 Latin America Acromegaly Market Size by Application 9.3.1 Latin America Acromegaly Market Size by Application (2016-2021) 9.3.2 Latin America Acromegaly Market Size by Application (2022-2027) 9.3.3 Latin America Acromegaly Market Size by Application (2016-2027) 9.4 Latin America Acromegaly Market Size by Country 9.4.1 Latin America Acromegaly Market Size by Country (2016-2021) 9.4.2 Latin America Acromegaly Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Acromegaly Market Size (2016-2027) 10.2 Middle East & Africa Acromegaly Market Size by Type 10.2.1 Middle East & Africa Acromegaly Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Acromegaly Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Acromegaly Market Size by Type (2016-2027) 10.3 Middle East & Africa Acromegaly Market Size by Application 10.3.1 Middle East & Africa Acromegaly Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Acromegaly Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Acromegaly Market Size by Application (2016-2027) 10.4 Middle East & Africa Acromegaly Market Size by Country 10.4.1 Middle East & Africa Acromegaly Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Acromegaly Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis 11.1.1 Novartis Company Details 11.1.2 Novartis Business Overview 11.1.3 Novartis Acromegaly Introduction 11.1.4 Novartis Revenue in Acromegaly Business (2016-2021) 11.1.5 Novartis Recent Development 11.2 Aegis Therapeutics 11.2.1 Aegis Therapeutics Company Details 11.2.2 Aegis Therapeutics Business Overview 11.2.3 Aegis Therapeutics Acromegaly Introduction 11.2.4 Aegis Therapeutics Revenue in Acromegaly Business (2016-2021) 11.2.5 Aegis Therapeutics Recent Development 11.3 Chiasma 11.3.1 Chiasma Company Details 11.3.2 Chiasma Business Overview 11.3.3 Chiasma Acromegaly Introduction 11.3.4 Chiasma Revenue in Acromegaly Business (2016-2021) 11.3.5 Chiasma Recent Development 11.4 Crinetics Pharmaceuticals 11.4.1 Crinetics Pharmaceuticals Company Details 11.4.2 Crinetics Pharmaceuticals Business Overview 11.4.3 Crinetics Pharmaceuticals Acromegaly Introduction 11.4.4 Crinetics Pharmaceuticals Revenue in Acromegaly Business (2016-2021) 11.4.5 Crinetics Pharmaceuticals Recent Development 11.5 Daewoong Pharmaceutical 11.5.1 Daewoong Pharmaceutical Company Details 11.5.2 Daewoong Pharmaceutical Business Overview 11.5.3 Daewoong Pharmaceutical Acromegaly Introduction 11.5.4 Daewoong Pharmaceutical Revenue in Acromegaly Business (2016-2021) 11.5.5 Daewoong Pharmaceutical Recent Development 11.6 Peptron 11.6.1 Peptron Company Details 11.6.2 Peptron Business Overview 11.6.3 Peptron Acromegaly Introduction 11.6.4 Peptron Revenue in Acromegaly Business (2016-2021) 11.6.5 Peptron Recent Development 11.7 Silence Therapeutics 11.7.1 Silence Therapeutics Company Details 11.7.2 Silence Therapeutics Business Overview 11.7.3 Silence Therapeutics Acromegaly Introduction 11.7.4 Silence Therapeutics Revenue in Acromegaly Business (2016-2021) 11.7.5 Silence Therapeutics Recent Development 11.8 Strongbridge Biopharma 11.8.1 Strongbridge Biopharma Company Details 11.8.2 Strongbridge Biopharma Business Overview 11.8.3 Strongbridge Biopharma Acromegaly Introduction 11.8.4 Strongbridge Biopharma Revenue in Acromegaly Business (2016-2021) 11.8.5 Strongbridge Biopharma Recent Development 11.9 Amryt Pharma 11.9.1 Amryt Pharma Company Details 11.9.2 Amryt Pharma Business Overview 11.9.3 Amryt Pharma Acromegaly Introduction 11.9.4 Amryt Pharma Revenue in Acromegaly Business (2016-2021) 11.9.5 Amryt Pharma Recent Development 11.10 Foresee Pharmaceuticals 11.10.1 Foresee Pharmaceuticals Company Details 11.10.2 Foresee Pharmaceuticals Business Overview 11.10.3 Foresee Pharmaceuticals Acromegaly Introduction 11.10.4 Foresee Pharmaceuticals Revenue in Acromegaly Business (2016-2021) 11.10.5 Foresee Pharmaceuticals Recent Development 11.11 Glide Pharmaceutical 11.11.1 Glide Pharmaceutical Company Details 11.11.2 Glide Pharmaceutical Business Overview 11.11.3 Glide Pharmaceutical Acromegaly Introduction 11.11.4 Glide Pharmaceutical Revenue in Acromegaly Business (2016-2021) 11.11.5 Glide Pharmaceutical Recent Development 11.12 Ionis Pharmaceuticals 11.12.1 Ionis Pharmaceuticals Company Details 11.12.2 Ionis Pharmaceuticals Business Overview 11.12.3 Ionis Pharmaceuticals Acromegaly Introduction 11.12.4 Ionis Pharmaceuticals Revenue in Acromegaly Business (2016-2021) 11.12.5 Ionis Pharmaceuticals Recent Development 11.13 Ipsen 11.13.1 Ipsen Company Details 11.13.2 Ipsen Business Overview 11.13.3 Ipsen Acromegaly Introduction 11.13.4 Ipsen Revenue in Acromegaly Business (2016-2021) 11.13.5 Ipsen Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Acromegaly Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Somatostatin Analogues Table 3. Key Players of Dopamine Agonists Table 4. Key Players of Growth Hormone Receptor Antagonists Table 5. Key Players of Other Table 6. Global Acromegaly Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Acromegaly Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Acromegaly Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Acromegaly Market Share by Regions (2016-2021) Table 10. Global Acromegaly Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Acromegaly Market Share by Regions (2022-2027) Table 12. Acromegaly Market Trends Table 13. Acromegaly Market Drivers Table 14. Acromegaly Market Challenges Table 15. Acromegaly Market Restraints Table 16. Global Acromegaly Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Acromegaly Market Share by Players (2016-2021) Table 18. Global Top Acromegaly Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acromegaly as of 2020) Table 19. Ranking of Global Top Acromegaly Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Acromegaly Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Acromegaly Product Solution and Service Table 23. Date of Enter into Acromegaly Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Acromegaly Market Size by Type (2016-2021) (US$ Million) Table 26. Global Acromegaly Revenue Market Share by Type (2016-2021) Table 27. Global Acromegaly Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Acromegaly Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Acromegaly Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Acromegaly Revenue Market Share by Application (2016-2021) Table 31. Global Acromegaly Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Acromegaly Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Acromegaly Market Size by Type (2016-2021) (US$ Million) Table 34. North America Acromegaly Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Acromegaly Market Size by Application (2016-2021) (US$ Million) Table 36. North America Acromegaly Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Acromegaly Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Acromegaly Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Acromegaly Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Acromegaly Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Acromegaly Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Acromegaly Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Acromegaly Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Acromegaly Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Acromegaly Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Acromegaly Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Acromegaly Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Acromegaly Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Acromegaly Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Acromegaly Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Acromegaly Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Acromegaly Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Acromegaly Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Acromegaly Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Acromegaly Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Acromegaly Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Acromegaly Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Acromegaly Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Acromegaly Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Acromegaly Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Acromegaly Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Acromegaly Market Size by Country (2022-2027) & (US$ Million) Table 63. Novartis Company Details Table 64. Novartis Business Overview Table 65. Novartis Acromegaly Product Table 66. Novartis Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 67. Novartis Recent Development Table 68. Aegis Therapeutics Company Details Table 69. Aegis Therapeutics Business Overview Table 70. Aegis Therapeutics Acromegaly Product Table 71. Aegis Therapeutics Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 72. Aegis Therapeutics Recent Development Table 73. Chiasma Company Details Table 74. Chiasma Business Overview Table 75. Chiasma Acromegaly Product Table 76. Chiasma Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 77. Chiasma Recent Development Table 78. Crinetics Pharmaceuticals Company Details Table 79. Crinetics Pharmaceuticals Business Overview Table 80. Crinetics Pharmaceuticals Acromegaly Product Table 81. Crinetics Pharmaceuticals Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 82. Crinetics Pharmaceuticals Recent Development Table 83. Daewoong Pharmaceutical Company Details Table 84. Daewoong Pharmaceutical Business Overview Table 85. Daewoong Pharmaceutical Acromegaly Product Table 86. Daewoong Pharmaceutical Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 87. Daewoong Pharmaceutical Recent Development Table 88. Peptron Company Details Table 89. Peptron Business Overview Table 90. Peptron Acromegaly Product Table 91. Peptron Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 92. Peptron Recent Development Table 93. Silence Therapeutics Company Details Table 94. Silence Therapeutics Business Overview Table 95. Silence Therapeutics Acromegaly Product Table 96. Silence Therapeutics Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 97. Silence Therapeutics Recent Development Table 98. Strongbridge Biopharma Company Details Table 99. Strongbridge Biopharma Business Overview Table 100. Strongbridge Biopharma Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 101. Strongbridge Biopharma Recent Development Table 102. Amryt Pharma Company Details Table 103. Amryt Pharma Business Overview Table 104. Amryt Pharma Acromegaly Product Table 105. Amryt Pharma Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 106. Amryt Pharma Recent Development Table 107. Foresee Pharmaceuticals Company Details Table 108. Foresee Pharmaceuticals Business Overview Table 109. Foresee Pharmaceuticals Acromegaly Product Table 110. Foresee Pharmaceuticals Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 111. Foresee Pharmaceuticals Recent Development Table 112. Glide Pharmaceutical Company Details Table 113. Glide Pharmaceutical Business Overview Table 114. Glide Pharmaceutical Acromegaly Product Table 115. Glide Pharmaceutical Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 116. Glide Pharmaceutical Recent Development Table 117. Ionis Pharmaceuticals Company Details Table 118. Ionis Pharmaceuticals Business Overview Table 119. Ionis Pharmaceuticals Acromegaly Product Table 120. Ionis Pharmaceuticals Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 121. Ionis Pharmaceuticals Recent Development Table 122. Ipsen Company Details Table 123. Ipsen Business Overview Table 124. Ipsen Acromegaly Product Table 125. Ipsen Revenue in Acromegaly Business (2016-2021) & (US$ Million) Table 126. Ipsen Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Acromegaly Market Share by Type: 2020 VS 2027 Figure 2. Somatostatin Analogues Features Figure 3. Dopamine Agonists Features Figure 4. Growth Hormone Receptor Antagonists Features Figure 5. Other Features Figure 6. Global Acromegaly Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. Clinics Case Studies Figure 9. Acromegaly Report Years Considered Figure 10. Global Acromegaly Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Acromegaly Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Acromegaly Market Share by Regions: 2020 VS 2027 Figure 13. Global Acromegaly Market Share by Regions (2022-2027) Figure 14. Global Acromegaly Market Share by Players in 2020 Figure 15. Global Top Acromegaly Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acromegaly as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Acromegaly Revenue in 2020 Figure 17. Global Acromegaly Revenue Market Share by Type (2016-2021) Figure 18. Global Acromegaly Revenue Market Share by Type (2022-2027) Figure 19. North America Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Acromegaly Market Share by Type (2016-2027) Figure 21. North America Acromegaly Market Share by Application (2016-2027) Figure 22. North America Acromegaly Market Share by Country (2016-2027) Figure 23. United States Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Acromegaly Market Share by Type (2016-2027) Figure 27. Europe Acromegaly Market Share by Application (2016-2027) Figure 28. Europe Acromegaly Market Share by Country (2016-2027) Figure 29. Germany Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Acromegaly Market Share by Type (2016-2027) Figure 37. Asia-Pacific Acromegaly Market Share by Application (2016-2027) Figure 38. Asia-Pacific Acromegaly Market Share by Region (2016-2027) Figure 39. China Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Acromegaly Market Share by Type (2016-2027) Figure 47. Latin America Acromegaly Market Share by Application (2016-2027) Figure 48. Latin America Acromegaly Market Share by Country (2016-2027) Figure 49. Mexico Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Acromegaly Market Share by Type (2016-2027) Figure 53. Middle East & Africa Acromegaly Market Share by Application (2016-2027) Figure 54. Middle East & Africa Acromegaly Market Share by Country (2016-2027) Figure 55. Turkey Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Acromegaly Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Novartis Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 59. Aegis Therapeutics Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 60. Chiasma Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 61. Crinetics Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 62. Daewoong Pharmaceutical Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 63. Peptron Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 64. Silence Therapeutics Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 65. Strongbridge Biopharma Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 66. Amryt Pharma Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 67. Foresee Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 68. Glide Pharmaceutical Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 69. Ionis Pharmaceuticals Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 70. Ipsen Revenue Growth Rate in Acromegaly Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Novartis Aegis Therapeutics Chiasma Crinetics Pharmaceuticals Daewoong Pharmaceutical Peptron Silence Therapeutics Strongbridge Biopharma Amryt Pharma Foresee Pharmaceuticals Glide Pharmaceutical Ionis Pharmaceuticals Ipsen